Safety and Efficacy Study of EVO101 Topical Cream in Atopic Dermatitis

Completed · Phase 2

Conditions studied: Atopic Dermatitis Eczema

In brief

This is a Phase 2a safety and efficacy study of EVO101 for the treatment of adults with atopic dermatitis

Key facts

Study ID
NCT05579899
Run by
Evommune, Inc.
People needed
119
Starts
2022-09-27
Expected to finish
2023-07-27
Last updated by the study team
2025-03-05

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.